Our board sets out our strategic priorities and policies. 

It has 2 sub-committees:

  • audit and risk committee
  • remuneration committee.
Find out more about board committees

Non-executive directors

Sharmila Nebhrajani OBE, chairman

Sharmila Nebhrajani OBE

Sharmila read medicine at the University of Oxford, graduating with first class honours in physiological sciences. Rather than pursuing further clinical studies, she began an international business career in finance and strategy, specialising in telecoms, infrastructure and technology. She had a 14 year career at the BBC including 9 years as chief operating officer at BBC Future Media and Technology, the division that built the iPlayer.

She has significant health and science experience having served on the boards of the Medical Research Council, the Association of Medical Research Charities, as deputy chairman of the Human Fertilisation and Embryology Authority and as chairman of the Human Tissue Authority.

She was most recently chief executive of Wilton Park, a not-for-profit agency of the Foreign and Commonwealth Office convening international policy dialogues on topics such as global health, regional and national security, climate change and artificial intelligence. She sits on a range of UK boards including Severn Trent plc, ITV plc, National Savings and Investments and Coutts. She was also a World Fellow at the University of Yale.

Sharmila was made an OBE in 2014 for services to medical research.

Dr Mark Chakravarty

Dr Mark Chakravarty

Mark is a business leader and physician, who brings more than 20 years’ experience in leading organisations. These include Novartis, Procter and Gamble and the NHS. His international career spans life sciences, healthcare, and consumer goods. Within these he has worked in medical, scientific, and external relations and brand and communications.

Most recently, he was the global head of communications and patient advocacy for Novartis Pharmaceuticals.

Previously, Mark has led communications for P&G’s feminine and family care business.

Mark is the vice chair and the lead non-executive director for the technology appraisal and highly specialised technologies appeals process.

Jackie Fielding

Jackie Fielding

Jackie has been in the healthcare industry for around 30 years, including 28 years with Medtronic. She was their vice president for the last 10 of those years and has held a number of external posts, including chair of the British Cardiovascular Intervention Association and a council member of the British Cardiovascular Intervention Society.

In November 2010, Jackie was elected to sit on the board of directors of the Association of British HealthTech Industries. She continues to do so following re-election after her term ended in 2012. In 2015, she took the role of vice chair. She has also been a member of the Ministerial Medical Technology Strategy Group.

Jackie joined NEOSS as a non-executive director in 2016 and held this position for 2 years. In 2019, she joined the board of 3D LifePrints as a non-executive director.

Jackie is passionate about authentic leadership and a strong believer that culture drives results. She also speaks about women in leadership and the value of diversity, inclusion, and engagement in the workplace.

Professor Gary Ford CBE, FMedSci

Professor Gary Ford CBE

Gary is chief executive officer of Oxford Academic Health Science Network. He is also a consultant stroke physician at Oxford University Hospitals NHS Foundation Trust, and professor of stroke medicine at Oxford University. He is the current chair of 15 Academic Health Science Networks across England.

He has been part of many service innovations in UK stroke care in the last 20 years. This includes developing the first thrombolysis protocol for acute stroke in England and the Face Arm Speech Test.

Gary was director of the National Institute for Health Research (NIHR) stroke research network from 2005 to 2014. He was awarded a CBE in 2013 for services to research in stroke medicine. He is a member of the NIHR strategy board. In 2018, Gary was identified as one of 7 NIHR research legends whose work has transformed care in the NHS.

Dame Elaine Inglesby-Burke DBE

Elaine Inglesby-Burke DBE

Elaine has been a registered nurse since 1980. Her previous roles include being a nurse specialist manager at St Helens and Knowsley Hospital Trust and director of nursing at The Walton Centre in Liverpool. She was previously chief nursing officer for the Northern Care Alliance NHS Group, which comprises Salford Royal NHS Foundation Trust and Pennine Acute NHS Trust. Currently she is the senior lead (COVID-19 support) at NHS England and Improvement in the North West. She is also a trustee for the Willowbrook Hospice in St Helens.

Elaine has also played a significant role in national health campaigns, having been a member of the Prime Minister’s Nursing and Care Quality Forum. She was also involved with the Berwick National Advisory Group on the Safety of Patients in England, a group of healthcare experts that was set up to examine patient safety issues in the NHS.

Elaine was awarded a DBE for her services to nursing.

Alina Lourie

Alina Lourie

Alina has had a long career in publishing and information within the private sector, including 16 years at Thomson Reuters. Her leadership has focused on the digital transformation of information for professional markets, including health. She was previously the managing director of the publishing arm of the Royal Pharmaceutical Society, which publishes a wide range of digital medicines information, including the British National Formulary (BNF).

Today, Alina holds a portfolio of board and advisory positions across several professional and academic bodies. These include the Institute of Engineering and Technology, the Royal Society of Chemistry and Manchester University Press.

Professor Bee Wee CBE

Professor Bee Wee

Originally from Malaysia, Bee qualified from Trinity College Dublin in 1988, trained in general practice in Dublin, then moved into palliative medicine in Ireland, Hong Kong and the UK. As national clinical director for end of life care she led the Leadership Alliance for the Care of Dying People and is co-chair of the National Partnership for Palliative and End of Life Care.

Professor Wee is also consultant in palliative medicine at Sobell House and Katharine House Hospices, Oxford University Hospitals NHS Foundation Trust and associate professor at University of Oxford, where she is also a fellow of Harris Manchester College.

Dr Justin Whatling

Dr Justin Whatling

Dr Justin Whatling is a medical doctor with 20 years’ experience in using technology and informatics to transform outcomes for patients. He leads health and life sciences for Palantir internationally. Prior to that he established and led Cerner's population health business outside of the USA. Justin held previous roles in BT Health, Accenture and ran a health outcomes business on behalf of Bupa

He is a founding fellow and member of the finance and audit committee and recent council member of the UK Faculty of Clinical Informatics. He is a fellow of the British Computer Society (BCS) and a member of their Academy of Computing board. He represents them on the management committee of the BMJ Health and Care Informatics journal and is a past chair for BCS Health. He also founded the Federation of Informatics Professionals.

Justin is a visiting professor in health informatics at University College London. He was previously an independent member of the NHS’s National Information Board, who set the strategy and direction for the health and care system in England on technology and information.

He has also completed 3 terms of office as a non-executive director of the BMJ publishing group. He has sat on the healthcare strategic advisory team of the Engineering and Physical Sciences Research Council.

Back to top

Executive directors

Dr Sam Roberts, chief executive

Dr Sam Roberts

Dr Sam Roberts is the chief executive of NICE.

Before joining us in February 2022, Sam was the managing director of health and care at Legal and General, a financial services firm. In this role, she had responsibility for identifying promising areas for investment across health and care.

Prior to that, Sam was the first chief executive of the Accelerated Access Collaborative. This is a national umbrella organisation for health innovation, hosted by NHS England and NHS Improvement (NHSEI).

She originally trained as a doctor and practiced medicine in South Africa, the UK, and Australia before undertaking an MBA. She then joined McKinsey and Company, where she worked in a wide range of industries before specialising in healthcare.

After McKinsey, Sam moved into the NHS as a senior manager at University College London Hospitals NHS Foundation Trust. She was also a director in UCLPartners, an Academic Health Sciences Centre and Network. Last year, she took on the role of director of innovation, research and life sciences at NHSEI.

Over the last 5 years Sam has become involved in research, working with health economic models to inform evidence-based policy at the London School of Economics. She then moved to the University of Oxford where she undertook a DPhil (Doctor of Philosophy).

Meindert Boysen, deputy chief executive and director of the Centre for Health Technology Evaluation

Meindert Boysen

After qualifying as a pharmacist, Meindert worked in a hospital in the Netherlands and held positions in health outcomes and sales in the pharmaceutical industry.

He completed an MSc in Health Policy Planning and Financing at the London School of Hygiene and Tropical Medicine and the London School of Economics and Political Sciences and briefly worked for the King’s Fund before starting at NICE in 2004.

Meindert was previously on the board of directors for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), from 2017 to 2020.

Dr Paul Chrisp, director of the Centre for Guidelines

Dr Paul Chrisp

Paul has been with us since March 2009, where he was responsible for setting up our accreditation programme for guideline developers. More recently, he was programme director of the Medicines and Technologies Programme.

Before joining us, Paul spent over 20 years in international medical publishing and communications, focusing on evidence to aid healthcare decision making and the adoption of new medicines.

Paul trained as a pharmacist and is a member of the Royal Pharmaceutical Society.

Jennifer Howells, director of finance, strategy and transformation

Jennifer Howells

Jennifer joined us in 2020 and is our chief financial officer. She is responsible for our strategy, transformation programme, and corporate services including finance, procurement, and corporate governance.

Jennifer worked for over 16 years within health systems, including as a regional director for NHS England and Improvement and as a chief executive and finance director for several commissioning and provider trusts. Before joining the NHS, Jennifer worked for a number of years in business advisory roles. She specialised in mergers and acquisitions in the UK, Europe and USA, including advising life science companies.

Alexia Tonnel, director of digital, information and technology

Alexia Tonnel

Alexia joined us in 2012 as director of evidence resources. She supervised a range of functions, including the information specialist and digital services teams. In 2020 she took responsibility for the IT function to lead the Digital, Information and Technology Directorate. The directorate design, develop and maintain our externally facing digital operations, maintain our internal guidance production systems and manage IT operations.

Alexia studied business and management in France, after which she completed a Master of Science in International Accounting and Finance at the London School of Economics and Political Science. Before joining us, Alexia was a director with Deloitte and advised a range of clients in the healthcare and life science industries on policy and strategy development and programme implementation.

Back to top


The following are not voting members of the board; along with the executive directors, they make up our executive team.

Nicole Gee, interim chief people officer

Nicole joined us in August 2021 and is an experienced HR practitioner with a focus on organisational design and change.

She is an expert in working with senior leaders to develop simple and effective strategies and pragmatically implementing them. She has established a reputation for integrity, challenging where necessary, and working collaboratively to achieve the best outcome.

Before joining us, Nicole played key roles at the Foreign, Commonwealth and Development Office to integrate the Foreign Office with the Department for International Development. She has also managed a range of organisation design projects across the private sector including Costa, Dixons Carphone, Tesco, Unilever and Easyjet.

Jane Gizbert, director of communications

Jane Gizbert

Jane joined us in 2008 and is responsible for the delivery of our strategic communications programme. Jane graduated from the University of New Brunswick in Canada with a BA Honours degree in Political Science. She subsequently obtained an MA in this field from Carleton University in Ottawa and went on to undertake a graduate journalism programme at the same university.

Jane was previously the head of corporate communications at the Medical Research Council, the UK's largest publicly funded medical research organisation. Her remit covered the full spectrum of corporate communications, including strategic development, public involvement and consultation, media relations and brand management.

Jane has worked extensively in the political field in Canada, including as press secretary for the official opposition and former prime minister of Canada and as director of communications for the Canadian Federation of Labour. Jane has also held senior positions in charitable organisations including the Scout Association and the International Planned Parenthood Federation.

Dr Felix Greaves, director of science, evidence and analytics

Dr Felix Greaves

Felix joined us in 2020 in the new role of director of science, evidence and analytics. He was previously the deputy director of science and strategic information and head of science and engineering profession at Public Health England. He has been closely involved in the development of our public health guidelines.

With 16 years’ experience in the health service, Felix has worked as a clinical advisor to the chief medical officer for England, a medical officer at the World Health Organization, and governor of an NHS foundation trust. Felix is a consultant in public health medicine and continues to work part time as a public health academic at Imperial College London.

Judith Richardson, acting director of health and social care

Judith Richardson

Judith is responsible for leading the implementation of guidance and quality standards across health, public health and social care. She joined us in 2007 and, as well as being our deputy medical director, has held roles with the clinical guidelines team, managed the development of NICE Pathways and led a portfolio of programmes including quality standards and indicators.

Judith originally trained in medicine in London, completing further training in public health and general practice. She then worked in public health for 15 years, holding a range of positions at local, regional, and national levels. She continues to have a training role in public health.

Back to top